DGHMC
XRTX

Dalton, Greiner, Hartman, Maher & Co’s XYRATEX LTD (BERMUDA) XRTX Stock Holding History

Dalton, Greiner, Hartman, Maher & Co’s Portfolio XRTX Stock Details XRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-128,044
Closed -$1.7M – 199
2014
Q1 		$1.7M Sell
128,044
-8,868
-6% -$117K 0.1% 113
2013
Q4 		$1.82M Buy
136,912
+19,152
+16% +$205K 0.11% 114
2013
Q3 		$1.31M Buy
+117,760
New +$1.26M 0.09% 135

Dalton, Greiner, Hartman, Maher & Co's XRTX Position: Q2 2014 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of XYRATEX LTD (BERMUDA) (XRTX) in Q2 2014, closing a stake of 128,044 shares — an estimated $1.7M sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in XRTX in Q3 2013 and held it in 3 quarters. The position peaked at $1.82M in Q4 2013. 0 funds tracked by Wall St. Rank hold XRTX as of Q2 2014.

  • Dalton, Greiner, Hartman, Maher & Co reported no remaining XYRATEX LTD (BERMUDA) position as of Q2 2014 after selling out during the quarter.
  • Dalton, Greiner, Hartman, Maher & Co sold 128,044 XYRATEX LTD (BERMUDA) shares in Q2 2014, an estimated $1.7M.
  • Dalton, Greiner, Hartman, Maher & Co first reported a position in XYRATEX LTD (BERMUDA) in Q3 2013 and held it in 3 quarters.
  • Dalton, Greiner, Hartman, Maher & Co's XYRATEX LTD (BERMUDA) position peaked at $1.82M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held XYRATEX LTD (BERMUDA) as of Q2 2014.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q2 2014, filed 11 Jul 2014.